The Community Oncology Alliance (COA) applauded President Donald Trump, HHS Secretary Alex Azar, Inspector General Daniel Levinson, and HHS staff for staking a strong stance against rebates and proposing to overal the current system.
The Community Oncology Alliance (COA) applauded President Donald Trump, HHS Secretary Alex Azar, Inspector General Daniel Levinson, and HHS staff for staking a strong stance against rebates and proposing to overal the current system. ASaccording to COA, the proposal will lower drug prices for all Americans by ensuring that they receive negotiated drug discounts, rather then plan sponsors and pharmacy benefit managers (PBMs).
COA also encouraged the administration to fix direct and indirect renumeration fees that PBMs get from pharmacy providers, which also drive up drug list prices. Read the full press release.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Oncology Practices Keep Pace With PBMs, in Court and Beyond
April 5th 2024This panel at the Community Oncology Alliance conference discussed the impact of pharmacy benefit manager (PBM) response to the end of direct and indirect remuneration fees, which has been dramatic cuts to cancer drug reimbursement.
Read More